Investigator Brian K. Kim, M.D

Sutter Health Research Enterprise
11795 Education Street
Suite 232
Auburn, CA, 95602
(888) 729-3488
kimbk@sutterhealth.org

Primary Research Interests

Related Clinical Trials

City of Hope 96144 Molecular Genetics Studies of Cancer Patients and Their Relatives

The purpose of this study is to find out how genetics, biologics and behavior might contribute to

Investigators: Kristin N. Arreola M.D., Kristie A. Bobolis M.D., Rajeswari Chellappah M.D., Brian K. Kim M.D, Sivakumar Reddy M.D., Vijay Suhag M.D.

Status: Active, Recruiting

Imaging of T-cell Activation With [18F]F-AraG in Advanced NSCLC

Pilot study using [18F]F AraG PET imaging to evaluate the immunological response to checkpoint inhibitor therapy (CkIT) in patients with advanced NSCLC

Investigators: Deepti Behl MD, Brian K. Kim M.D, Vijay Suhag M.D.

Status: Active, Recruiting

Locally Advanced (TIGeR-PaC Study)

Multi-center, un-blinded, randomized control study of subjects with locally advanced pancreatic adenocarcinoma which is unresectable.

Investigators: Deepti Behl MD, Brian K. Kim M.D, Christopher J Laing M.D., Sivakumar Reddy M.D., Vijay Suhag M.D.

Status: Active, Recruiting

Napoli 3-Ipsen (D-US-60010-001)

Randomized, Multicentre, Phase III Study of Irinotecan Liposome Injection, Oxaliplatin, 5-fluorouracil/Leucovorin Versus Nab-paclitaxel Plus Gemcitabine

Investigators: Kristin N. Arreola M.D., Deepti Behl MD, Brian K. Kim M.D, Jasdeepa Nagi M.D., Sivakumar Reddy M.D.

Status: Active, Recruiting